M Mirjam Hempenius (Mirjam Hempenius)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Top Venues

Pharmacoepidemiology and drug safety

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

M Mirjam Hempenius, S H Sophie Bots, R H H Rolf Groenwold, A Ton de Boer, O H Olaf Klungel, H Helga Gardarsdottir
Bias in observational studies on the effectiveness of in hospital use of hydroxychloroquine in COVID-19. Pharmacoepidemiology and drug safety (2023)
M Mirjam Hempenius, Simone Rijken, Rolf H H Groenwold, Karin Hek, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study. British journal of clinical pharmacology (2022)
M Mirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact. Pharmacoepidemiology and drug safety 30 (12) (2021)
M Mirjam Hempenius, Rolf H H Groenwold, Patrick C Souverein, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants. British journal of clinical pharmacology 87 (9) (2021)
M Mirjam Hempenius, Kim Luijken, Anthonius de Boer, Olaf Klungel, Rolf Groenwold, Helga Gardarsdottir
Quality of reporting of drug exposure in pharmacoepidemiological studies. Pharmacoepidemiology and drug safety 29 (9) (2020)
M Mirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, Olaf H Klungel, Helga Gardarsdottir
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions. Pharmacoepidemiology and drug safety 28 (12) (2019)